Nonetheless, other studies have shown beneficial effects of the blockage of IL-6 and its signaling pathway in the control of skeletal muscle wasting and cachexia progression in several mouse cancer models (Holmer et al. 2014; Narsale and Carson 2014; Pelosi et al. 2014). Here, IL6 is linked to cancer.